API Innovation Center

A non-profit organization dedicated to enabling the delivery of market-competitive commercial supply of U.S.-made active pharmaceutical ingredients.

[Senate Aging Committee @SenateAging]

🚨 CONSUMER ALERT: Right now 25% of generic prescriptions in the U.S. are from facilities with an FDA violation according to @api_innovation.

Why? Because they are made in Communist China and India in facilities that fail to meet our standards. It’s not safe—we must fix this NOW.

[theSTL @in_thestl]

St. Louis is leading the fight against U.S. drug shortages by bringing active pharmaceutical ingredient production back to the U.S. through the API Innovation Center. @HEC_TV https://t.co/GFuirrR1hY #STLMade

[Missouri Partnership @MOPartnership]

The @api_innovation's efforts to strengthen the U.S. pharmaceutical supply chain & make #MO a leader in #API production is also expected to strengthen Missouri’s #economy. https://t.co/hubqet7NEg

#Bioscience #HumanHealth #Healthcare #PharmaceuticalManufacturing #STL

[Polsinelli @Polsinelli]

We are thrilled to share we recently advised client API Innovation Center on their successful application to obtain funding by the Administration for Strategic Preparedness and Response’s Center for Industrial Base Management & Supply Chain: https://t.co/wrzKZMNEMJ.

#healthcare

[API Innovation Center @api_innovation]

@ASPRgov The @api_innovation center is proud to be working with @ASPRgov on this groundbreaking initiative to drive API manufacturing in the U.S. and improve national health security!

[HHS ASPR @ASPRgov]

Under Defense Production Act Title III, we’re working to reshore pharmaceutical manufacturing. Today, we announced a $14M award to increase the biomanufacturing of key starting materials (KSM) & active pharmaceutical ingredients (APIs) in the US. https://t.co/klYjsscAko

[WashU Olin Business School @washuolin]

On September 25, 2024, the Washington University Center for Analytics and Business Insights (CABI) is partnering with the API Innovation Center to discuss the future of pharmaceutical manufacturing in Missouri.

Register now 🔗 https://t.co/8RP2wAeOe7

#washu #washuolin

[Missouri Chamber @MissouriChamber]

We’re excited to be in STL for the Advanced Pharmaceutical Manufacturing Technology Conference, co-hosted by @api_innovation and the Missouri Technology Alliance.

The Missouri Chamber is proud to support this event and help foster an environment that attracts & retains tech talent.

[API Innovation Center @api_innovation]

Drug shortages and supply chain issues continue to threaten patients in need of life-saving treatments. We are proud to participate in discussions around Advanced Manufacturing Technologies and supply chain reliability with the @DukeMargolis ReVAMP Drug Supply Chain Consortium.

[API Innovation Center @api_innovation]

We are proud to be working with the @MissouriChamber on a strategic plan to increase our state’s manufacturing competitiveness.

Register for a FREE roundtable near you: https://t.co/hoaMgiDfpd

[API Innovation Center @api_innovation]

Our COO was at @CPHI_Events North America this week! Kevin Webb participated in a panel discussion on "Reshoring U.S. Pharma: The Realities" as part of the Supply Chain Economy track sponsored by @USPharmacopeia

Read more: https://t.co/WsvQtHhKXP

[Missouri Chamber @MissouriChamber]

The API Innovation Center has reached a major milestone in bringing the production of lomustine, a critical cancer drug, to the U.S. It's an important step in positioning Missouri as a hub for essential pharmaceutical manufacturing. Congrats!

Read more ⬇️ https://t.co/alLlYC3u3z

[API Innovation Center @api_innovation]

Congratulations to @MilliporeSigma on this opening. This is an excellent addition to the St. Louis region!

[MilliporeSigma @MilliporeSigma]

We're taking our oligo offerings up a notch! We opened our company's first cGMP Oligonucleotide Manufacturing suite in St. Louis, MO, USA, expanding our oligo offerings to include cGMP quality oligos for the diagnostic and clinical markets.

Learn more: https://t.co/5TXzYar7bd

[API Innovation Center @api_innovation]

We're thrilled to work with @USPharmacopeia to help ensure access to critical medicines through #supplychain resilience and #advanced manufacturing!

[U.S. Pharmacopeia @USPharmacopeia]

#ATTN: We're pleased to announce a strategic collaboration with @api_innovation to help end #DrugShortages in America. Together, we'll harness #SupplyChain insights + advanced technologies to ensure access to critical meds. Read more: https://t.co/bg6au1ivEF

[U.S. Pharmacopeia @USPharmacopeia]

#ATTN: We're pleased to announce a strategic collaboration with @api_innovation to help end #DrugShortages in America. Together, we'll harness #SupplyChain insights + advanced technologies to ensure access to critical meds. Read more: https://t.co/bg6au1ivEF

[API Innovation Center @api_innovation]

We released a new #whitepaper informed by experts in the #pharmaceutical industry, outlining recommendations for reshoring the manufacture of essential, life-saving pharmaceuticals.
Read the paper here: https://t.co/yCDjUzBU6R

[Greater St. Louis, Inc. @GreaterSTLinc]

NEW CUTTING-EDGE FACILITY COMING TO NORTH STL — A milestone moment was reached this morning as @GovParsonMO, @saintlouismayor & other leaders gathered to break ground for the new home of the Advanced Manufacturing Innovation Center St. Louis. https://t.co/aQNiq3IOFw

[API Innovation Center @api_innovation]

We are excited to share our agenda for our event, Pathway to Build Supply Chain Resilience for Critical Drugs.

📌 Highlights: 
🔷 Date: November 8th 
🔷 Location: St. Louis, MO
🔷 Registration: https://t.co/gK0TdxDsYj

[API Innovation Center @api_innovation]

Kevin Webb, COO, was a panelist for
@TheWilsonCenter and @USPharmacopeia's
“Building a High Quality US-Mexico Pharmaceutical Supply Chain” seminar.

You can watch the full event here:
https://t.co/najquGJsoH

[U.S. Pharmacopeia @USPharmacopeia]

#ICYMI: Three of the most reliable factors contributing to #DrugShortages are
💊manufacturing complexity;
💊low drug prices; and
💊production concentration.
Read more from #USP experts and others who shared insights at our event in partnership with @ACSCAN + @AmericanCancer. ⤵️